Philosophy of Care
My clinical interests include strategies to improve long-term outcomes in transplant recipient and educational programs for community nephrologists and primary care providers to strengthen their knowledge in caring for transplant recipients.
My research interests are focused on the role of surveillance biopsies in improving renal allograft outcomes and immunosuppressive protocols in kidney and pancreas transplantation.
UC Davis Transplant Center
Cypress Building, Transplant Surgery
2221 Stockton Blvd., Suite B
Sacramento, CA 95817
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
M.D., Kilpauk Medical College, Chennai, 1985
M.R.C.P., Royal College of Physicians of the United Kingdom Accredited Training Hospitals, 1988
Mayo Clinic, Rochester, MN, 1993-1995
Royal College of Physicians of the United Kingdom Accredited Training Hospitals, 1986-1988
Stobhill General Hospital, Glasgow, 1988-1990
Toronto General & Western Hospitals, Toronto, 1990-1992
University of Arkansas for Medical Sciences, Little Rock, AR, 1992-1993
American Society of Transplantation
Association of Physicians of India
Royal College of Physicians of the United Kingdom
Select Recent Publications:
de Mattos, A.M., Olyaei, A.J., Prather, J.C., Golconda, M.S., Barry, J.M., Norman, D.J. Autosomal Dominant Polycystic Kidney Disease as a risk factor for Diabetes Mellitus following renal transplantation. Kidney International 2005; 67(2): 714-20.
Keith D.S. DeMattos A. Golconda M. Prather J. Cantarovich M. Paraskevas S. Tchervenkov J. Norman DJ. Factors associated with improvement in deceased donor renal allograft function in the 1990s. J. Am. Soc. Nephrol 2005; 16(5): 1512-21.
Barry JM. Conlin M. Golconda M. Norman D. Strategies to increase living donor kidney transplants. Urology 2005; 66(5 Suppl): 43-6
Keith, D.S., de Mattos, A.M., Golconda, M., Prather, J., Norman, D. Effect of donor recipient age match on survival after first deceased donor renal transplantation. J. Am. Soc. Nephrol 2004; 15(4): 1086-91.
Whiting, J.F., Golconda, M., Hayes, R., Smith, R., O’Brien, S., First, M.R., Alexander, J.W. Economic costs of Expanded Criteria Donors in Renal Transplantation. Transplantation 1998; 65(2): 204-7.
Golconda, M.S., Larson, T.S., Kolb, L., Kumar, R. 1,25-dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient. Mayo Clinic Proceedings 1996; 71(1): 32-36.
Golconda, Muralikrishna. S., Ueda, N., Shah, S.V. Evidence suggesting that iron and calcium are interrelated in oxidant-induced DNA damage. Kidney International 1993; 44: 1228-1234.
Czapla K., Rodger, R.S., Halls, D.J., Muralikrishna, G.S., Macdougall, A.I., Fell, G.S. Ranitidine reduces aluminium toxicity in patients with renal failure. Nephrol Dial Transplant 1992; 7(12): 1246 - 8.
Rodger, R.S., Muralikrishna, G.S., Halls, D.J., Henderson, J.B., Forrest, J.A., Macdougall, A.I., Fell, G.S. Ranitidine suppresses aluminium absorption in man. Clinical Science 1991; 80(5): 505-508.
Muralikrishna, G.S., Rodger, R.S., Macdougall, A.I., Boulton-Jones, J.M., Allison, M.E., Kyle, K.F., Junor, B.J., Briggs, J.D. Renal replacement therapy in patients with spina bifida or spinal cord injury. Br. Med. J 1989; 299(6714): 1506.
Muralikrishna, G.S., Yasoda, T., Subash, S., Venkatesan, S., Sayeed, Z.A., Rajagopalan, R.S. Familial hypokalemic periodic paralysis. J Assoc Physician India 1983; 31(5): 316-8.